Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines
- 4 November 2007
- journal article
- research article
- Published by Elsevier BV in Toxicology
- Vol. 243 (1-2), 236-243
- https://doi.org/10.1016/j.tox.2007.10.023
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands do not potentiate growth of human cancer cell linesCarcinogenesis: Integrative Cancer Research, 2007
- Activation of PPARδ inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblastsCardiovascular Research, 2007
- Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ-deficient miceThe EMBO Journal, 2007
- Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKTEuropean Journal of Pharmacology, 2007
- PPARβ/δ Protects Against Experimental Colitis Through a Ligand-Independent MechanismDigestive Diseases and Sciences, 2007
- Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cellsGut, 2002
- PPARα and PPARδ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cellsEuropean Journal of Pharmacology, 2002
- Critical roles of PPARβ/δ in keratinocyte response to inflammationGenes & Development, 2001
- Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant miceThe Journal of cell biology, 2001
- Modulation of Keratinocyte Gene Expression and Differentiation by PPAR-Selective Ligands and Tetradecylthioacetic AcidJournal of Investigative Dermatology, 2001